“Ruxolitinib Cream Is Associated With Reduced Treatment Burden in Atopic Dermatitis: A US Payer Claim Analysis”. 2025. SKIN The Journal of Cutaneous Medicine 9 (6): s591. https://doi.org/10.25251/9yfem502.